Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Adverum Biotechnologies, Inc (ADVM)  
$7.60 0.23 (2.94%) as of 4:30 Fri 5/24


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 101,000,000
Market Cap: 767.60(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.7528 - $16.06
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 9.5
Insider 3/6 Months : 10.1
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Co.'s primary product candidate, ADVM-022, is a single, in-office intravitreal (IVT) injection gene therapy product. ADVM-022 is being developed for the treatment of patients with wet age-related macular degeneration who are responsive to anti-vascular endothelial growth factor therapy. Co.'s second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to deliver a functional copy of the OPN1LW gene to the foveal cones of patients suffering from blue cone monochromacy via a single IVT injection.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 230,000 330,000 330,000
Total Buy Value $0 $310,500 $455,990 $455,990
Total People Bought 0 2 3 3
Total Buy Transactions 0 2 3 3
Total Shares Sold 0 0 6,201 140,082
Total Sell Value $0 $0 $9,429 $134,803
Total People Sold 0 0 1 5
Total Sell Transactions 0 0 1 9
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 266
  Page 10 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gasmi Mehdi VP, Pharmaceutical Development   •       –      –    2015-04-14 4 AS $39.45 $39,448 D/D (1,000) 0     -
   Gasmi Mehdi VP, Pharmaceutical Development   •       –      –    2015-04-14 4 OE $2.75 $2,750 D/D 1,000 1,000     -
   Zygtech, Llc 10% Owner   –       –       •   2015-04-14 4 AS $39.93 $183,663 D/D (4,600) 2,438,176     -
   Zygtech, Llc 10% Owner   –       –       •   2015-04-13 4 AS $39.09 $805,009 D/D (20,400) 2,442,776     -
   Wachter Paul Director   –       •      –    2015-04-13 4 AS $39.10 $46,896 I/I (1,192) 47,889     -
   Schwartz Steven Daniel Director   –       •      –    2015-04-09 4 AS $39.72 $685,278 D/D (17,250) 451,056     -
   Blumenkranz Mark S. Director   –       •      –    2015-04-08 4 AS $39.94 $99,841 D/D (2,500) 620,989     -
   Gasmi Mehdi VP, Pharmaceutical Development   •       –      –    2015-04-07 4 AS $38.59 $347,425 D/D (9,000) 0     -
   Gasmi Mehdi VP, Pharmaceutical Development   •       –      –    2015-04-07 4 OE $2.75 $24,750 D/D 9,000 9,000     -
   Blumenkranz Mark S. Director   –       •      –    2015-04-07 4 AS $38.59 $115,808 I/I (3,000) 11,531     -
   Blumenkranz Mark S. Director   –       •      –    2015-04-07 4 AS $38.59 $868,560 D/D (22,500) 623,489     -
   Hull Hans SVP, Business Operations   •       –      –    2015-04-07 4 AS $38.59 $1,061,573 D/D (27,500) 3,320     -
   Hull Hans SVP, Business Operations   •       –      –    2015-04-07 4 OE $0.19 $5,225 D/D 27,500 30,820     -
   Zygtech, Llc 10% Owner   –       –       •   2015-01-13 4 S $55.46 $5,546,000 D/D (100,000) 2,463,176     -
   Wachter Paul Director   –       •      –    2015-01-13 4 S $55.46 $776,440 I/I (14,000) 49,081     -
   Chalberg Thomas W. Chief Executive Officer   •       •      –    2015-01-13 4 S $55.46 $4,714,100 D/D (85,000) 285,988     -
   Schwartz Steven Daniel Director   –       •      –    2015-01-13 4 S $55.46 $5,046,860 D/D (91,000) 468,306     -
   Blumenkranz Mark S. Director   –       •      –    2015-01-13 4 S $55.46 $5,546,000 D/D (100,000) 645,989     -
   Chalberg Thomas W. Chief Executive Officer   •       •      –    2014-12-12 4 GA $0.00 $0 I/I 413 413     -
   Chalberg Thomas W. Chief Executive Officer   •       •      –    2014-12-12 4 GD $0.00 $0 D/D 413 370,988     -
   Chalberg Thomas W. Chief Executive Officer   •       •      –    2014-12-12 4 OE $0.21 $87 D/D 413 371,401     -
   Koh Bong Y 10% Owner   –       –       •   2014-08-05 4 B $17.00 $6,800,000 I/I 400,000 2,365,471 1.5     -
   Koh Bong Y 10% Owner   –       –       •   2014-08-05 4 A $0.00 $0 I/I 1,965,471 1,965,471     -
   Vhcp Management Ii, Llc 10% Owner   –       –       •   2014-08-05 4 B $17.00 $6,800,000 I/I 400,000 2,365,471 1.5     -
   Vhcp Management Ii, Llc 10% Owner   –       –       •   2014-08-05 4 A $0.00 $0 I/I 1,965,471 1,965,471     -
  266 Records found
  Previous  10  11   
  Page 10 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us